1. Home
  2. CPSS vs CRBP Comparison

CPSS vs CRBP Comparison

Compare CPSS & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

HOLD

Current Price

$9.11

Market Cap

208.7M

Sector

Finance

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$9.22

Market Cap

184.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSS
CRBP
Founded
1991
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.7M
184.4M
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
CPSS
CRBP
Price
$9.11
$9.22
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$45.50
AVG Volume (30 Days)
23.8K
419.1K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
1.27
N/A
EPS
0.24
N/A
Revenue
$434,470,000.00
$4,822,272.00
Revenue This Year
$147.09
N/A
Revenue Next Year
N/A
$116.00
P/E Ratio
$39.29
N/A
Revenue Growth
10.41
97.62
52 Week Low
$6.67
$7.12
52 Week High
$10.49
$20.56

Technical Indicators

Market Signals
Indicator
CPSS
CRBP
Relative Strength Index (RSI) 51.19 53.41
Support Level $9.40 $8.19
Resistance Level $9.53 $9.73
Average True Range (ATR) 0.31 0.47
MACD 0.01 -0.00
Stochastic Oscillator 67.74 50.00

Price Performance

Historical Comparison
CPSS
CRBP

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: